Provoking the Immunotherapy Efficacy of Renal Medullary Carcinoma
RNA-seq (gene expression) · human · 48 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 48 samples: 8 conditions, mostly with about 7 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Sickle cell disease induces chromatin introversion and ferroptosis in CD8(+) T cells to suppress anti-tumor immunityImmunity · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE240845_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1005476 and SRA study SRP435455. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 48 samples.
How we read this: 8 replicated groups read from 48 sample titles; they account for 48 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7267937 healthy donor GYY treated 1 healthy donor GYY treat…
- GSM7267938 healthy donor GYY treated 2 healthy donor GYY treat…
- GSM7267939 healthy donor GYY treated 3 healthy donor GYY treat…
- GSM7267940 healthy donor GYY treated 4 healthy donor GYY treat…
- GSM7267941 healthy donor GYY treated 5 healthy donor GYY treat…
- GSM7267942 healthy donor GYY treated 6 healthy donor GYY treat…
- GSM7267944 healthy donor GYY treated 7 healthy donor GYY treat…
- GSM7267945 healthy donor vehicle treated 1 healthy donor vehicle t…
- GSM7267946 healthy donor vehicle treated 2 healthy donor vehicle t…
- GSM7267947 healthy donor vehicle treated 3 healthy donor vehicle t…
- GSM7267948 healthy donor vehicle treated 4 healthy donor vehicle t…
- GSM7267949 healthy donor vehicle treated 5 healthy donor vehicle t…
- GSM7267950 healthy donor vehicle treated 6 healthy donor vehicle t…
- GSM7267951 healthy donor vehicle treated 7 healthy donor vehicle t…
- GSM7267952 SCA patient GYY treated 1 SCA patient GYY treated
- GSM7267953 SCA patient GYY treated 2 SCA patient GYY treated
- GSM7267955 SCA patient GYY treated 3 SCA patient GYY treated
- GSM7267956 SCA patient GYY treated 4 SCA patient GYY treated
- GSM7267957 SCA patient GYY treated 5 SCA patient GYY treated
- GSM7267958 SCA patient GYY treated 6 SCA patient GYY treated
- GSM7267959 SCA patient GYY treated 7 SCA patient GYY treated
- GSM7267960 SCA patient vehicle treated 1 SCA patient vehicle tre…
- GSM7267961 SCA patient vehicle treated 2 SCA patient vehicle tre…
- GSM7267962 SCA patient vehicle treated 3 SCA patient vehicle tre…
- GSM7267963 SCA patient vehicle treated 4 SCA patient vehicle tre…
- GSM7267965 SCA patient vehicle treated 5 SCA patient vehicle tre…
- GSM7267966 SCA patient vehicle treated 6 SCA patient vehicle tre…
- GSM7267967 SCA patient vehicle treated 7 SCA patient vehicle tre…
- GSM7710128 GYY4137+IgG, biological replicate 1 GYY4137+IgG,
- GSM7710129 GYY4137+IgG, biological replicate 2 GYY4137+IgG,
- GSM7710130 GYY4137+IgG, biological replicate 3 GYY4137+IgG,
- GSM7710131 GYY4137+IgG, biological replicate 4 GYY4137+IgG,
- GSM7710132 GYY4137+IgG, biological replicate 5 GYY4137+IgG,
- GSM7710133 GYY4137+PD1, biological replicate 1 GYY4137+PD1,
- GSM7710134 GYY4137+PD1, biological replicate 2 GYY4137+PD1,
- GSM7710135 GYY4137+PD1, biological replicate 3 GYY4137+PD1,
- GSM7710136 GYY4137+PD1, biological replicate 4 GYY4137+PD1,
- GSM7710137 GYY4137+PD1, biological replicate 5 GYY4137+PD1,
- GSM7710138 Veh+IgG, biological replicate 1 Veh+IgG,
- GSM7710139 Veh+IgG, biological replicate 2 Veh+IgG,
+ 8 more — browse all 48 samples with per-sample file links →
- GSE235246 Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma impair CD8+ T cell activation and responsiveness to immunotherapy in mice 38 samples shares immunotherapy
- GSE282660 Salsalate improves the anti-tumor efficacy of Lenvatinib in MASH-driven hepatocellular carcinoma. 36 samples shares efficacy
- GSE266364 Immunogenic cell death inducer cEmsy boosted cancer immunotherapy in lung adenocarcinoma 33 samples shares immunotherapy
- GSE319486 Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma 18 samples shares efficacy
- GSE294901 Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor: results from PNOC005 84 samples shares immunotherapy
- GSE274229 Evolution of myeloid-mediated immunotherapy resistance in prostate cancer 52 samples shares immunotherapy
- GSE280148 SOAT1 knockout enhances sensitivity of liver cancer cells to T cell-based immunotherapy [RNA-seq] 24 samples shares immunotherapy
- GSE260551 Trabectedin Promotes Oncolytic Virus Antitumor Efficacy, Viral Gene Expression, and Immune Effector Function in Models of Bone Sarcoma 12 samples shares efficacy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.